Vigil Neuroscience, Inc.
VIGL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $69,136 | $130,847 | $396,064 | $347,396 |
| - Cash | $39,019 | $51,992 | $186,605 | $91,420 |
| + Debt | $12,945 | $13,850 | $176 | $937 |
| Enterprise Value | $43,062 | $92,705 | $209,635 | $256,913 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$453 | -$399 | -$1,010 | -$345 |
| % Margin | – | – | – | – |
| EBITDA | -$83,803 | -$88,467 | -$68,227 | -$42,381 |
| % Margin | – | – | – | – |
| Net Income | -$84,256 | -$82,638 | -$68,305 | -$43,252 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.07 | -2.13 | -2.16 | -1.57 |
| % Growth | 2.8% | 1.4% | -37.6% | – |
| Operating Cash Flow | -$51,223 | -$70,363 | -$65,149 | -$39,347 |
| Capital Expenditures | -$5 | -$674 | -$921 | -$204 |
| Free Cash Flow | -$51,228 | -$71,037 | -$66,070 | -$39,551 |